首页 | 本学科首页   官方微博 | 高级检索  
     

干细胞移植治疗糖尿病下肢血管病变的Meta分析
引用本文:夏稳伸,何仁姣,艾金伟,王君,李德胜,裴斌. 干细胞移植治疗糖尿病下肢血管病变的Meta分析[J]. 中国组织工程研究, 2021, 0(19): 3110-3116
作者姓名:夏稳伸  何仁姣  艾金伟  王君  李德胜  裴斌
作者单位:锦州医科大学湖北医药学院研究生培养基地;湖北医药学院附属襄阳市第一人民医院骨三科;湖北医药学院附属襄阳市第一人民医院循证医学中心;湖北医药学院附属襄阳市第一人民医院心血管内科
基金项目:湖北省卫生计生西医类2015-2016年度一般项目(WJ2015MB187),项目负责人:裴斌;湖北医药学院教研重点项目(2015025),项目负责人:裴斌;襄阳市科技计划项目(2010GG3A21),项目负责人:裴斌。
摘    要:目的:干细胞移植己用于糖尿病下肢血管病变的临床治疗,因各研究样本量小,研究结论不一致.文章系统评价干细胞移植治疗糖尿病下肢血管病变的有效性和安全性.方法:计算机检索PubMed、The Cochrane Library(2019年第11期)、EMbase、中国知网、CBM、维普、万方数据库中干细胞移植治疗糖尿病下肢血管...

关 键 词:干细胞  糖尿病  血管  下肢  细胞  截肢  随机对照试验  Meta分析

Stem cell transplantation for diabetic patients with lower-extremity arterial disease:a meta-analysis
Xia Wenshen,He Renjiao,Ai Jinwei,Wang Jun,Li Desheng,Pei Bin. Stem cell transplantation for diabetic patients with lower-extremity arterial disease:a meta-analysis[J]. Chinese Journal of Tissue Engineering Research, 2021, 0(19): 3110-3116
Authors:Xia Wenshen  He Renjiao  Ai Jinwei  Wang Jun  Li Desheng  Pei Bin
Affiliation:(Postgraduate Training Basement of Jinzhou Medical University,Hubei University of Medicine,Xiangyang 441000,Hubei Province,China;Third Department of Orthopedics,Xiangyang No.1 People’s Hospital,Hubei University of Medicine,Xiangyang 441000,Hubei Province,China;Evidence-Based Medicine Center,Xiangyang No.1 People’s Hospital,Hubei University of Medicine,Xiangyang 441000,Hubei Province,China;Department of Cardiology,Xiangyang No.1 People’s Hospital,Hubei University of Medicine,Xiangyang 441000,Hubei Province,China)
Abstract:OBJECTIVE:Stem cell transplantation has been used in the clinical treatment of diabetic lower limb vascular diseases.The conclusions were inconsistent due to the small sample size of each study.This article systematically reviewed the safety and efficacy of stem cells transplantation for diabetic patients with lowerextremity arterial disease.METHODS:PubMed,The Cochrane Library(Issue 11,2019),EMbase,CNKI,CBM,VIP and Wanfang databases were electronically searched to collect randomized controlled trials of stem cell transplantation for diabetic patients with lower-extremity arterial disease from inception to December 10,2019.Two reviewers independently screened literature,extracted data and assessed risk of bias of included studies.Meta-analysis was then performed using RevMan 5.3 software.RESULTS:A total of 13 randomized controlled trials involving 546 patients,with 287 patients in stem cell transplantation group and 259 patients in conventional treatment group were included.The meta-analysis results showed that compared with the conventional treatment group,stem cell transplantation could significantly decrease the rate of lower limb amputation(RR=0.29,95%CI:0.10-0.84,P=0.02),improve the collateral angiogenesis(RR=3.16,95%CI:2.12-4.70,P<0.00001),increase ankle brachial pressure index(MD=0.17,95%CI:0.10-0.24,P<0.00001),transcutaneous oxygen pressure(MD=7.71,95%CI:3.99-11.43,P<0.00001),skin temperature(MD=1.90,95%CI:1.28-2.53,P<0.00001)and intermittent limp distance(MD=150.61,95%CI:43.49-257.74,P=0.006),reduce the scores of rest pain(MD=-1.16,95%CI:-1.92 to-1.30,P<0.00001),and cold feeling(MD=-2.00,95%CI:-2.49 to-1.50,P<0.00001).No severe complications such as death,neoplasm,or hepatorenal function impairment were observed in all of our included studies.CONCLUSION:Stem cell transplantation maybe an effective and safe therapeutic method for diabetic patients with lower-extremity arterial disease.However,due to the limited quantity and quality of included studies,more high-quality,long-term follow-up and large sample size randomized controlled trials are needed to confirm the above conclusions.
Keywords:stem cell  diabetes mellitus  blood vessel  lower extremity  cell  amputation  randomized controlled trial  meta-analysis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号